Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma Cells by Tilghman, Syreeta L. et al.
Endocrine Disruptor Regulation of MicroRNA Expression
in Breast Carcinoma Cells
Syreeta L. Tilghman
1,2., Melyssa R. Bratton
2,3., H. Chris Segar
4, Elizabeth C. Martin
4, Lyndsay V.
Rhodes
4,M e n gL i
5, John A. McLachlan
2,3, Thomas E. Wiese
1,2, Kenneth P. Nephew
5, Matthew E.
Burow
2,4*
1Division of Basic Pharmaceutical Sciences, College of Pharmacy, Xavier University of Louisiana, New Orleans, Louisiana, United States of America, 2Center for
Bioenvironmental Research, Tulane University, New Orleans, Louisiana, United States of America, 3Department of Pharmacology, Tulane University, New Orleans,
Louisiana, United States of America, 4Department of Medicine, Section of Hematology and Medical Oncology, Tulane University, New Orleans, Louisiana, United States of
America, 5Department of Medical Sciences, School of Medicine, Indiana University, Bloomington, Indiana, United States of America
Abstract
Background: Several environmental agents termed ‘‘endocrine disrupting compounds’’ or EDCs have been reported to bind
and activate the estrogen receptor-a (ER). The EDCs DDT and BPA are ubiquitously present in the environment, and DDT
and BPA levels in human blood and adipose tissue are detectable in most if not all women and men. ER-mediated biological
responses can be regulated at numerous levels, including expression of coding RNAs (mRNAs) and more recently non-
coding RNAs (ncRNAs). Of the ncRNAs, microRNAs have emerged as a target of estrogen signaling. Given the important
implications of EDC-regulated ER function, we sought to define the effects of BPA and DDT on microRNA regulation and
expression levels in estrogen-responsive human breast cancer cells.
Methodology/Principal Findings: To investigate the cellular effects of DDT and BPA, we used the human MCF-7 breast
cancer cell line, which is ER (+) and hormone sensitive. Our results show that DDT and BPA potentiate ER transcriptional
activity, resulting in an increased expression of receptor target genes, including progesterone receptor, bcl-2, and trefoil factor
1. Interestingly, a differential increase in expression of Jun and Fas by BPA but not DDT or estrogen was observed. In
addition to ER responsive mRNAs, we investigated the ability of DDT and BPA to alter the miRNA profiles in MCF-7 cells.
While the EDCs and estrogen similarly altered the expression of multiple microRNAs in MCF-7 cells, including miR-21,
differential patterns of microRNA expression were induced by DDT and BPA compared to estrogen.
Conclusions/Significance: We have shown, for the first time, that BPA and DDT, two well known EDCs, alter the expression
profiles of microRNA in MCF-7 breast cancer cells. A better understanding of the molecular mechanisms of these
compounds could provide important insight into the role of EDCs in human disease, including breast cancer.
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Introduction
Organochlorine pesticides and plasticizing agents are ubiquitous
environmental endocrine disrupting compounds with the potential
to negatively impact human health [1]. We along with others have
demonstrated that the hormonal (estrogenic) activity of these
compounds, including o,p9-dichlorodiphenyltrichloroethane
(DDT) and bisphenol A (BPA), is mediated through direct binding
to the estrogen receptor a (ERa) and subsequent receptor
activation [2,3]. Furthermore, the ER-mediated mechanisms of
‘‘environmental estrogens’’ include both ER-dependent and -
independent regulation of gene expression and cell signaling [3,4],
and recent studies have shown that nuclear hormone receptors
(NHRs), including androgen receptor (AR), luteinizing hormone
receptor (LHR) and thyroid hormone receptor (THR), represent
additional targets of endocrine disruptors [5–7]. Endocrine
disruptors function through targeted agonistic or antagonistic
interactions with NHRs, ultimately leading to changes in gene
expression. Although the majority of NHR- functional effects are
mediated by changes in mRNA transcription, recent studies have
demonstrated regulation of microRNA expression as an important
mechanism in transcriptome networks.
MicroRNAs, a specific class of endogenous non-coding RNAs
highly conserved across species, are single-stranded RNAs of 21–
25 nucleotides in length [8]. MicroRNAs regulate mRNA stability
and translation by targeting the 39UTR of target mRNAs and
inducing translational silencing [9]. More than 700 microRNAs
have been identified in the human genome, and over one-third of
all human genes are potentially regulated by microRNAs [10].
MicroRNAs have been associated with many biological processes
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role for microRNAs in hormone signaling has recently been
described [14], including estrogen regulation of microRNA
expression in the hormone responsive MCF-7 breast cancer cells
[15–17], and these studies further demonstrate that direct targets
of ERa include miR-206, miR-155, miR-125b, miR-145 and
miR-21.
miR-21 plays a role in many cell systems, ranging from cardiac
hypertrophy [18,19], to haematopoietic lineage differentiation
[20], and oncogenesis [21–26]. Estrogen regulation of miR-21
expression has been reported and appears to be complex.
Compared to normal breast specimens, miR-21 is overexpressed
in the vast majority of breast tumor specimens [27], suggesting
that it may potentially act as an oncogene. While inhibition of
miR-21 expression has been associated with increased cell growth
in cancer [28], Si et al. demonstrated that inhibition of miR-21 by
anti-miR-21 oligonucleotides suppressed both cell growth in vitro
and tumor growth in vivo [29]. Estrogen-induced repression of
miR-21in MCF-7 breast cancer cells was inhibited by the
antiestrogens tamoxifen and fulvestrant, indicating that miR-21
is a direct target of ERa [17]. These data prompted miR-21 to be
labeled an ‘oncomiR,’ and miR-21 was found to be significantly
higher in ER positive tumors compared to ER negative tumors
[30]. Furthermore, an estrogen-mediated decrease in miR-21 was
correlated with increased expression of the miR-21 targets
PDCD4, PTEN and Bcl-2 at the protein level, which taken
together identifies miR-21 as an E2-ER-regulated microRNA in
MCF-7 cells [17].
Previous reports of estrogen-mediated regulation of microRNAs
suggest that endocrine disrupting compounds (EDCs) may also
influence microRNA expression. In support of this possibility, Hsu
et al. demonstrated that both estrogen and the xenoestrogen
diethylstilbestrol (DES) induced miR-9-3 expression in mammo-
sphere-derived epithelial cells, but to our knowledge, this is the
only report of EDC-regulation of microRNAs [31]. As EDCs can
exert a powerful influence on gene expression networks, we sought
to investigate a role for organochlorines and polycarbonates in the
regulation of microRNA expression. We utilized classic estrogen
responsive reporter gene assays and mRNA analysis of the ER
positive MCF-7 breast cancer cell line to initially examine specific
transcriptional changes induced my E2, BPA, and DDT, and we
subsequently used microRNA microarrays to identify EDC-
mediated changes in microRNA profiles. Our data show that
miR-21 was consistently downregulated by both EDCs tested.
Validation of our microRNA microarray findings in MCF-7 cells
further suggests that miR-21 expression is mediated by ERa and is
a potential regulator of estrogen- and EDC-induced gene
expression.
Results
Estrogen, BPA and DDT induce ERE transcriptional
activity in MCF-7 cells
To compare overall ERa transcriptional activity of two EDCs
(DDT and BPA) with E2 treatment, ERE reporter assays in MCF-
7 cells were performed. Results indicated an 8-fold increase in the
activity of ERa in cells treated with $50 pM E2 (Figure 1A), in
agreement with our and other groups previous studies [32,33].
Interestingly, DDT and BPA both induced transcriptional activity
of the ER; however, a full transcriptional response (i.e.,
comparable to E2) required higher concentrations of both agents
compared to estrogen (Figure 1B and 1C). The E2, DDT, and
BPA-induced transcriptional activity was suppressed by fulvestrant
and tamoxifen with all treatments observed, as expected.
BPA and DDT alter expression of estrogen responsive
genes
Although similarities between EDCs and E2 have been
described [34], the extent to which BPA and DDT mimic the
estrogen profile of select estrogen responsive genes is unclear. To
examine the regulation of specific ERa responsive genes by BPA
and DDT, we used a PCR array approach and identified genes
commonly altered by the three ERa ligands including PgR (211-,
166-, and 172-fold induction by BPA, DDT, and E2 respectively),
bcl-2 (2.7-, 2.9- and 2.7-fold induction by BPA, DDT, and E2,
respectively), and other well-known estrogen responsive genes
TFF1 (pS2), SERPINB5 and cathepsin D (Table 1). In addition,
GABA and gelsolin were downregulated by the EDCs and E2
(Table 1). Analysis of two genes, bcl-2 and SERPINB5, by qRT-
PCR yielded similar results compared to the array (Figure 2),
further validating the estrogenic activity of both DDT and BPA.
Interestingly, several genes were differentially regulated by the
three compounds. For example, Jun and Fas were increased by
approximately 1.8 and 1.5 fold by BPA but were relatively
unchanged by E2 and DDT (Table 1). These subtle changes in
gene expression mediated by the individual compounds prompted
us to investigate whether EDC’s might alter the microRNA
expression profile in MCF-7 breast cancer cells in a manner
distinct from that seen by estrogen.
E2, BPA and DDT alter patterns of miR-21 expression
Previous studies have shown that the onco-miR-21 is an
estrogen-regulated microRNA and as such, plays an important
role in breast cancer [25,27,35]. Based on the above results of our
transcriptional activation assays and gene expression analyses, we
investigated whether the EDCs could induce microRNA expres-
sion in hormone-responsive breast cancer cells. MCF-7 cells were
exposed to vehicle, 10 mM BPA, 10 mM DDT, or 1 nM E2 for
18 hours, followed by total RNA extraction and analysis using
microRNA microarrays of all known human microRNA species
identified by the Sanger miRbase. Heatmaps were generated to
compare the microRNA expression between treatments and
controls. As shown in Figure 3, a number of microRNAs were
significantly (p,0.01) altered by E2, DDT, and BPA. Treatment
with E2, BPA and DDT decreased (p,0.05) miR-21 expression
with a log 2 (G2/G1) value of 23.78, 23.72 and 20.93
respectively (Table 1). Several members of the let-7 family (let-
7a, let-7b, let-7c, let-7d, let-7e and let-7f), were downregulated
(p,0.05) by all three treatments, consistent with published data in
human breast cancer cells [36], and miR-15b (p,0.005) and miR-
27b (p,0.01) were also downregulated by the three treatments
(Table 2). In addition, upregulation of miR-638 (P,0.005), miR-
663 (P,0.005), and miR-1915 (P,0.005) was observed after
treatment of MCF7 cells with E2, BPA or DDT (Table 2). Results
from the microarray revealed many microRNAs were altered;
however, levels of only 95 microRNAs were significantly regulated
by the treatments. Interestingly, only five microRNAs were
significantly regulated by all three treatments as demonstrated
by the Venn diagram (Figure 4). In addition, the miR-21
microarray results were validated in MCF-7 cells by qRT-PCR
(Figure 5), with both estrogen and BPA significantly suppressing
miR-21 expression. Although the DDT treated cells showed an
overall trend of decreasing miR-21 expression, the results were not
statistically significant. To test the involvement of ERa in the
suppression of miR-21 by treatment with E2, BPA, or DDT, we
utilized MCF-7F cells which are derived MCF-7 cells that are
ERa-negative and estrogen-resistant [37]. We found that in an ER
(2) breast line E2 was unable to significantly alter expression of
miR-21 (Fig. 5B). Interestingly, in MCF-7F cells, BPA stimulated
Organochlorine Induction of miRNA-21
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miR-21 levels observed in the ERa (+) MCF-7 parental cells. The
differential regulation of miR-21 by BPA between the two cell lines
potentially reflects a role for BPA in regulation of distinct ER-
dependent and independent signaling mechanisms in these cell
systems. In any case, our results collectively demonstrate for the
first time the ability of the xenoestrogens BPA and DDT to
regulate microRNA expression in breast cancer cells, including
miR-21, an estrogen-regulated onco-miR in breast cancer.
Response of miR-21 regulated genes to DDT and BPA
exposure in MCF-7 cells
Previous studies have identified programmed cell death 4
(neoplastic transformation inhibitor) (PDCD4) and maspin as
direct targets of miR-21 [38]. PDCD4 is a putative target of miR-
21 and is implicated in the metastatic potential of pancreatic
tumors [39], and maspin is a well-known tumor suppressor that
can suppress tumor growth, invasion and metastasis [40]. Since
E2, BPA and DDT reduced miR-21expression in MCF-7 cells, it
was of interest to examine whether the effect of BPA and DDT
resulted in altered expression of the two miR-21 target genes.
MCF-7 cells were treated with increasing concentrations of BPA
and DDT, and expression of maspin and PDCD4 was examined
by RT-PCR. Results demonstrate a dose dependent increase in
the expression of maspin and PDCD4 by BPA and DDT
(Figure 6), suggesting that inhibition of miR-21 by DDT or BPA
resulted in the increased expression of these two miR-21 target
mRNAs. Interestingly, maspin appeared to be more sensitive to
BPA and DDT than PDCD4 (Figure 6).
Discussion
Understanding the cellular response to environmental endo-
crine disrupting chemicals is critical to defining the role of these
agents in human health. We and others have shown the estrogenic
potential of the plasticizer BPA and the insecticide DDT [41,42];
however, the underlying mechanisms by which these compounds
exert their effects and the biological endpoints that accompany
them are not fully understood. In this study, we compared the
estrogenic activity of BPA and DDT to that of the natural
hormone estrogen in the ER (+) breast cancer cell line MCF-7. By
using ERE-luciferase assays and quantitative PCR techniques, we
were able to show BPA and DDT influence estrogen receptor
Figure 1. ERE-luciferase assay in MCF-7 cells. Cells were incubated overnight in media containing 5% charcoal-stripped FBS and were then
transfected with an ERE-luciferase plasmid. After 4 hrs, drugs were added to the cells as indicated and luciferase levels were measured 18 hrs. later.
doi:10.1371/journal.pone.0032754.g001
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(Figures 1 and 2, Table 1). Although our PCR superarray data
revealed many genes were either up- or down-regulated by all
three compounds, the altered expression of several genes by either
DDT or BPA was observed, including Fas and Jun (Table 1).
Based on the differential mRNA expression patterns induced by
BPA and DDT, we hypothesized that these two endocrine
disruptors may induce distinct microRNA profiles in MCF-7 cells.
The analysis of estrogen responsive microRNAs across several cell
systems, including zebrafish [43], rat breast [44], human breast
[45], mouse uterus [46], human myometrium and leiomyoma
[23], and endometrium [47] has revealed patterns of estrogen-
induced microRNA expression; however, the effect of environ-
mental estrogens on microRNA expression in breast cancer cells
has not been determined. We observed both common and distinct
microRNA expression patterns in estrogen-treated MCF-7 cells.
For example, E2 caused a down-regulation of miR-21 in MCF-7
cells, as seen by others [17,45], while a unique E2-mediated
decrease in miR-27b was observed. Our data show a complex,
differential expression pattern of microRNA families induced by
each individual compound: estrogen, BPA, and DDT each altered
unique sets of microRNAs (Figure 4), strongly supporting our
hypothesis that the activity of these two known xenoestrogens
differs from the naturally occurring steroid hormone.
In breast cancer biopsies, increased expression of mir-21 has
recently been reported [48]. Our microRNA array results suggest
that in addition to E2, BPA and DDT affect endogenous levels of
miR-21 in MCF-7 breast cancer cells. We first confirmed the
microRNA array data showing E2, DDT, and BPA all
downregulated miR-21 expression, although consistent with the
array, DDT was not as effective as E2 or BPA (Figure 5). The
mRNAs encoding maspin and PDCD4 are known targets of miR-
21. We therefore confirmed that both BPA and DDT, in a dose-
dependent manner, increased the transcript levels of each protein,
consistent with a BPA- and DDT-mediated decrease in miR-21
levels (Figure 6). Recently, miR-21 was identified as being up-
regulated by E2 in MCF-7p cells, a derivative of MCF-7 cells
containing a bicistronic vector [16]. We can only speculate that
the differences seen in our report are due to slight variations in cell
lines (we used MCF-7 parental cells) or a difference in the amount
of time cells were exposed to the drugs. However, an E2-mediated
decrease in miR-21 was also reported by two groups using
parental MCF-7 cells [17,45]. Because elevated levels of miR-21
have been reported in breast tumor biopsies, an E2-mediated
decrease in miR-21 expression might seem counterintuitive.
However, the complex nature of breast tumor biology in vivo
differs markedly from in vitro cultured MCF-7 primary breast
cancer cells, and our results further indicate that microRNA
expression in breast cancer cells undergo dynamic changes as cells
transition from a primary, non-metastatic state (MCF-7) to that of
an aggressive breast tumor. In addition, our results in the ERa (2)
MCF-7F cells showing BPA stimulated an increase in miR-21
suggests an intriguing alternate mechanism by which BPA may
exert both ERa-dependent and independent effects on regulation
of coding and non-coding RNA levels (Fig. 5B). This observation
further supports emerging evidence that EDCs such as DDT and
BPA can influence multiple signaling cascades and gene expression
Figure 2. Quantitative PCR confirmation of select genes altered
by estrogen, BPA, and DDT in MCF-7 cells. MCF-7 cells were
treated with drug as indicated and total RNA was isolated, reverse-
transcribed into cDNA, and subjected to real-time RT-PCR analysis for
quantitation. Results are shown for (A) SERPINB5 (maspin) and (B) Bcl2
gene expression. Treatment of MCF-7 cells was as follows: Ethanol
(vehicle), 1 nM E2,1 0mM BPA, and 10 mM DDT. Results are expressed as
the mean fold induction 6 S.E.M. (***, p,0.001; **, p=0.01 – 0.001; *,
p=0.05 - 0.01).
doi:10.1371/journal.pone.0032754.g002
Table 1. SuperArray Analysis of Genes Altered by E2, BPA and DDT Treatment.
Gene Name Gene Symbol E2 BPA DDT
B-cell CLL/lymphoma 2 BCL2 2.68 2.93 0.93
Cathepsin D CTSD 2.53 2.68 2.41
Gamma-aminobutyric acid (GABA) A receptor, pi GABRP 26.83 25.39 23.36
Gelsolin (amyloidosis, Finnish type) GSN 22.45 22.76 23.12
Progesterone receptor PGR 172 211 166
Serpin peptidase inhibitor, clade B (ovalbumin), member 5 SERPINB5 5.81 4.44 3.75
Trefoil factor 1 TFF1 34 22 23
Jun JUN 1.09 1.88 1.17
Fas FAS 1.40 1.54 1.15
Gene expression profile of select genes from a SuperArray analysis showing significant changes in expression with E2, BPA or DDT treatment. Numbers indicate
significant –fold changes in gene expression.
doi:10.1371/journal.pone.0032754.t001
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first to show an effect of EDCs on microRNA expression levels in a
manner both similar and distinct from those seen by E2.
A role for global microRNA changes in response to environ-
mental signaling such as hypoxia, heavy metals, air pollution and
dioxins is supported by a number of recent studies [49,50]. The
commercial use of BPA is increasing in frequency and exposure to
BPA, through plastic beverage containers, has been shown to have
significant deleterious effects on the endocrine system [51].
Likewise, atmospheric deposition of DDT remains a critical
contaminant in the environment that has harmful effects on the
liver, reproductive system, nervous system and ultimately can lead
to cancer [52]. We show for the first time that both BPA and DDT
can elicit changes in microRNA expression in human breast
cancer cells, including oncomiR-21, supporting the possibility that
environmental compounds with estrogenic activity have the
potential to play an important role in breast carcinogenesis.
Defining the molecular mechanisms underlying EDC-induced
microRNA changes and the subsequent cellular consequences may
contribute to the emerging roles of microRNAs in human health
and disease.
Materials and Methods
Chemicals
4-Hydroxytamoxifen and BPA were purchased from Sigma-
Aldrich (St. Louis, MO). Fulvestrant (ICI 182,780) was purchased
from Tocris Bioscience (Ellisville, Missouri). o,p9 DDT was
purchased from AccuStandard (New Haven, CT).
Figure 3. MicroRNA microarray heatmaps of MCF-7 cells treated with vehicle, estrogen, BPA, or DDT. (A) Estrogen versus control (B) BPA
versus control and (C) DDT versus control. Arrowheads represent expression of miR-21.
doi:10.1371/journal.pone.0032754.g003
Organochlorine Induction of miRNA-21
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Human MCF-7 breast cancer cells were purchased from
American Type Culture Collection (Manassas, VA) and were
cultured in 75 cm
2 culture flasks in DMEM (Invitrogen, Co.)
supplemented with 5% FBS (Life Technologies, Inc., Gaithersburg,
MD), basic minimum MEM essential (506, Invitrogen Co.) and
MEM non-essential (1006, Invitrogen, Co.) amino acids, sodium
pyruvate (1006Invitrogen Co.), antimycotic-antibiotic (10,000 U/
mL penicillin G sodium; 10,000 mg/mL streptomycin sulphate;
25 mg/mL amphotericin B as FungizoneH). The culture flasks were
maintained in a tissue culture incubator in a humidified atmosphere
of 5% CO2 and 95% air at 37uC. For estrogen studies, cells were
washed with PBS three times and grown in phenol red-free DMEM
supplemented with 5% dextran-coated charcoal-treated FBS (5%
CS-FBS) for 48 h before plating for each particular experiment.
Luciferase Assays
MCF-7 cells were seeded at 50–60% confluency in 24-well plates
in DMEM containing 5% charcoal stripped fetal bovine serum (CS-
FBS). Twenty-four hours later, each well was transfected with
0.2 mg of ERE-luciferase plasmid (Panomics) using Effectene
(Qiagen) transfection reagent. Briefly, plasmid DNA was mixed
with EC buffer (75 mL/mg DNA), followed by the addition of
enhancer solution (3 mL/mg DNA). Samples were incubated at
room temperature for 5 minutes followed by addition of the
effectene reagent (6 uL/ug DNA). Samples were mixed and
incubated at room temperature for 10 minutes. The DNA was
then added to the cells. Four hours post transfection, either vehicle
(DMSO) or drug (estrogen, o,p9-DDT, or BPA) was added. Cell
lysates were harvested 18–24 hours later using MPER extraction
reagent (Pierce) and read in a Berthold luminometer using Bright
Glo luciferase assay reagent (Promega). Transfection efficiency was
normalized by total protein concentration of each sample using the
BCA assay (Pierce). Relative luminescence was calculated by
dividing raw luminescence values by total protein, and each value
is an average of three independent samples.
Figure 4. MicroRNA microarray of MCF-7 breast cancer cells treated with E2, BPA and DDT. Venn diagram showing the relative expression
profiles of microRNA’s from MCF-7 cells treated with estrogen vs BPA vs DDT.
doi:10.1371/journal.pone.0032754.g004
Table 2. MicroRNA microarray of MCF-7 cells.
Genes E2 BPA DDT
miR-21 23.78 23.72 20.93
miR-638 0.69 1.28 1.12
miR-663 1.03 1.72 1.17
miR-1915 1.21 1.70 1.43
let-7g 22.04 22.39 n/s
let-7c 21.36 20.79 n/s
miR-923 n/s 20.32 20.51
miR-93 1.02 0.71 n/s
miR-320a 1.28 0.96 n/s
miR-1308 n/s 0.92 1.63
let-7f 21.85 20.76 n/s
miR-15b 21.18 22.07 22.16
miR-1275 0.71 0.64 n/s
miR-27b 21.91 21.55 21.54
miR-222 0.99 1.19 n/s
miR-193a-5p 1.15 n/s 0.50
miR-16 21.44 n/s 20.71
miR-26b 22.35 23.34 n/s
miR-149 n/s 1.53 1.86
miR-92a 0.67 n/s 21.17
miR-99b 0.87 n/s 20.55
miR-92b 0.52 n/s 21.13
miR-342-3p n/s 20.99 20.65
MicroRNA microarray profile of MCF-7 cells treated with vehicle, E2, DDT, or BPA.
Numbers indicate significant –fold changes in microRNA expression compared
to vehicle.
doi:10.1371/journal.pone.0032754.t002
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MCF-7 cells were maintained in 10% FBS without phenol red.
MCF-7 cells were withdrawn from estrogen in 10% CS-FBS for 6
days prior to plating for treatment. Cells were seeded into 6-well
plates at 4610
5 cells/mL in 2.5 mL of 10% CS-FBS media per well
the day before treatment. On the following day cells were treated
with either vehicle, 1 nM E2,1 0mM BPA, or 10 mMo , p 9-DDT for
48 hours. Total RNA was extracted and quality was checked with
Experion (BioRad). Each array profiles the expression of a panel of
96 genes. For each array (n=3), 4 mg RNA was reverse transcribed
into cDNA using the First Strand Synthesis kit (SABiosciences) inthe
presence of gene-specific oligonucleotide primers as described in the
manufacturer’s protocol. cDNA template was mixed with the
appropriate ready-to-use PCR master mix, equal volumes were
aliquoted to eachwellofthesameplate,and a real-time PCR cycling
program was run. Quantitative RT-PCR was performed using
manufacturer’s protocols for the RT
2 Profiler
TM PCR Array
(Human Breast Cancer and Estrogen Receptor Signaling Super-
array, Gaithersburg, MD, USA). Relative gene expressions were
calculated using the 2
2DDCt method, in which Ct indicates the
fractional cycle number where the fluorescent signal reaches
detection threshold. The ‘delta–delta’ method uses the normalized
DCt value of each sample, calculated using a total of five endogenous
control genes (18S rRNA, HPRT1, RPL13A, GAPDH, and ACTB)
[53]. Fold change values are then presented as average fold
change=2
2(
average DDCt) for genes in treated relative to control
samples. Clinical variables were characterized using descriptive
statistics, and the statistical significance of differences in gene
expression between groups was calculated using the student’s t-test.
Real Time RT-PCR
Total cellular RNA was extracted using the RNeasyH mini
column (Qiagen), following the manufacturer’s instructions.
Reverse transcription (RT) was carried out using the SuperScript
First-Strand Synthesis System for RT-PCR (Invitrogen). One
microgram of total RNA was reverse transcribed to cDNA
following the manufacturer’s instructions. For each RT, a blank
was prepared using all the reagents except the RNA sample (for
which an equivalent volume of DEPC treated water was
substituted). This blank was used as a non-template control in
the real-time PCR experiments. The level of SERPINB5 (maspin)
and PDCD4 transcripts were determined using quantitative real-
time PCR. Primers for PCR were designed to span intron/exon
junctions to minimize amplification of residual genomic DNA.
The primer sequences for SERPINB5 and PDCD4 are (sense and
anti-sense, respectively): SERPINB5 (59- CCTGTTCCT-
TTTCCACGCATTTTC-39;5 9- CACCTTTAGCACCCACTT-
GAGC- -39) and PDCD4 (59-ATTTCAGCATCCTCCAT-
TAACG-39;5 9- GCCTATCCAGCAACCTTCC -39), PCR mix
contained optimal concentrations of primers, cDNA and SYBR
Green PCR Master Mix (Bio-Rad Lab). Quantification and
relative gene expression were calculated with internal controls with
an n=3. The ratio between these values provided the relative gene
expression levels.
MicroRNA Real Time RT PCR
MCF-7 cells were grown in 5% CS-FBS DMEM media for
48 hours prior to treatment with 100 pM 17-beta estrogen, 10 mm
BPA, 10 mm op’DDT, or DMSO for 18 hours. Cells were
harvested and total RNA extraction was performed using Qiagen
miRNeasy RNA purification system according to the manufac-
turer’s protocol. The quantity and quality of the total RNA was
determined by measuring the absorbance at 260 and 280 nm
using the NanoDrop ND-1000. 1.5 ug of total RNA was reverse-
transcribed using the Qiagen Reverse Transcription kit as per
manufacturer’s protocol. qPCR was performed using SYBR green
(Biorad) and primer for mature miR-21 (SAB Biosciences) as per
manufacturer’s protocol. Data was analyzed by comparing relative
microRNA expression to U6 RNA. Relative microRNA expres-
sion was analyzed using 2-DDCt method.
microRNA Microarray Analysis
The cells were treated for 18 hours with vehicle, E2,D D To rB P A
(n=3). microRNA was extracted using the miRNeasyH mini column
Figure 5. Effects of E2, BPA and DDT on miR-21 gene expression in MCF-7 and MCF-7F cells. MCF-7 cells (A) and MCF-7F cells (B) were
treated with either vehicle, 1 nM E2,1 0mM BPA, or 10 mM DDT. Total microRNA was extracted followed by RT-PCR. *=p,0.05, **=p,0.001.
doi:10.1371/journal.pone.0032754.g005
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was performed using a service provider (LC Sciences). The company
used 2 to 5 mg total RNA sample, which was size fractionated using a
YM-100 Microcon centrifugal filter (from Millipore) and the small
RNAs (,300 nt) isolated were 39-extended with a poly(A) tail using
poly(A) polymerase. An oligonucleotide tag was then ligated to the
poly(A) tail for later fluorescent dye staining; two different tags were
used for the two RNA samples in dual-sample experiments.
Hybridization was performed overnight on a mParaflo microfluidic
chip using a micro-circulation pump (Atactic Technologies) [54]. On
the microfluidic chip, each detection probe consisted of a chemically
modified nucleotide coding segment complementary to target micro-
RNA (from miRBase, http://microrna.sanger.ac.uk/sequences/) or
other RNA (control or customer defined sequences) and a spacer
segment of polyethylene glycol to extend the coding segment away
from the substrate. The detection probes were made by in situ synthesis
using PGR (photogenerated reagent) chemistry. The hybridization
melting temperatures were balanced by chemical modifications of the
detection probes. Hybridization used 100 mL 6xSSPE buffer (0.90 M
NaCl, 60 mM Na2HPO4, 6 mM EDTA, pH 6.8) containing 25%
formamide at 34uC. After hybridization detection used fluorescence
labeling using tag-specific Cy3 and Cy5 dyes. Hybridization images
were collected using a laser scanner (GenePix 4000B, Molecular
Device) and digitized using Array-Pro image analysis software (Media
Cybernetics). Data were analyzed by first subtracting the background
and then normalizing the signals using a LOWESS filter Locally-
weighted Regression [55]. A total of 4 technical replicates were used.
For two color experiments, the ratio of the two sets of detected signals
(log2 transformed, balanced) and p-values of the t-test were calculated;
differentially detected signals were those with less than 0.01 p-values.
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